Nordson Reports Record Q2 Results, Beats Expectations, and Raises Full-Year Sales & EPS Guidance
NDSN sits 40% above its 52-week low of $191.99.
Summary
Nordson Corporation announced record second-quarter fiscal 2026 results, surpassing analyst expectations for sales and adjusted earnings, and subsequently raised its full-year guidance.
Key Events · Earnings and Guidance · NDSN
-
Record Second Quarter Performance
Sales reached a record $741 million (up 8% year-over-year, 7% organic), with adjusted diluted EPS hitting a record $2.86 (up 18% year-over-year).
-
Increased Full-Year Guidance
The company raised its full-year sales outlook to a range of $2.93 billion to $3.01 billion and adjusted EPS guidance to a range of $11.30 to $11.80 per diluted share, reflecting continued market momentum and strong backlog.
-
Strong Backlog and Order Entry
Backlog increased 18% year-over-year, with broad-based order entry momentum across all segments, supporting future growth.
-
Strategic Acquisition Completed
Nordson completed a small, strategic acquisition of CapstanAG Systems, a precision agriculture company, expanding its portfolio in North America.
Analysis · NDSN · Technology
The company delivered strong Q2 performance with significant organic sales growth and an 18% increase in adjusted EPS, driven by effective execution of its Ascend Strategy. The increased full-year guidance for both sales and earnings indicates sustained positive momentum and improved outlook, which is a strong positive signal for investors.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NDSN was trading at $268.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $15.4B. The 52-week trading range was $191.99 to $305.28. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.